80.7% of the patients, the pregnancy rate per couple was 86.5% by IVF/ICSI and the take-home baby rate was 70.2%. The authors reported significantly larger testicular volume in the successful group than in the unsuccessful group. The time from SCI was significantly shorter, and serum luteinizing hormone as well as serum follicle-stimulating hormone were significantly lower in the successful group. Serum folliclestimulating hormone had the strongest association with successful sperm collection by TESE in SCI patients.As reported in the literature, after SCI men suffer from erectile dysfunction, ejaculatory dysfunction and abnormal semen quality. PVS is considered the first line of choice for managing anejaculation in this population. It has an 86% success rate in patients with a neurological level of injury at or rostral to T10.2 If PVS fails, electroejaculation is the next method of choice, if available, with almost 100% success rate.2 Autonomic dysreflexia can be managed by premedication (e.g. nifedipine) and monitoring vital signs.3 Surgical sperm retrieval is the last resort if PVS and electroejaculation fail to induce ejaculation. Although men with SCI have a normal sperm count, they present with low sperm motility and viability.4 Pregnancy rates range from 24% to 70% using intravaginal (home) insemination or intrauterine insemination, as reported in the literature.5 IVF/ ICSI in couples with an SCI male partner have shown similar pregnancy rates compared with couples with other male factor etiologies. 6 Although the authors acknowledged several study limitations, it still confirms previous reports of successful pregnancies using sperm from men with SCI. It is worth noting that elective sperm cryopreservation is not a medical necessity in this population based on reports showing no decline in semen quality after chronic SCI.